Intravesical bacillus Calmette-Guérin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder
Authors:
- Doron GraussDGDoron Grauss
- Dov EngelsteinDEDov Engelstein
- Avishai SellaASAvishai Sella
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, 1997
- Low Dose Pasteur Bacillus Calmette-Guerin Regimen in Stage T1, Grade 3 Bladder Cancer TherapyJournal of Urology, 1996
- Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.Journal of Clinical Oncology, 1995
- Radical Cystectomy for Stages TA, TIS and T1 Transitional Cell Carcinoma of the BladderJournal of Urology, 1994
- Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCGUrology, 1993
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Results of 6 Weekly Intravesical Bacillus Calmette-Guerin Instillations on the Treatment of Superficial Bladder TumorsJournal of Urology, 1988
- Radical cystectomy for historical and pathologic T1, N0, MO (stage A) transitional cell cancerUrology, 1988
- A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.Journal of Clinical Oncology, 1987
- Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder CancerJournal of Urology, 1987